Thea Loise Woodward
Fifteen technology companies that have secured Intel Capital investments are helping government agencies, health care facilities and private entities respond to the coronavirus pandemic with innovation.
Intel said Friday its venture capital arm pumped at least $100M into small and medium businesses that now offer platforms to support COVID-19 response efforts.
VeriSIM Life built a biosimulation-based modeling technology that seeks to help drugmakers analyze data sets from clinical studies and predict the potential effect of pharmaceutical compounds on the human body.
DataRobot provides data scientists access to an enterprise artificial intelligence platform through a White House-sponsored COVID-19 research challenge. The platform worked to generate models that have the potential to determine which U.S. counties are susceptible to the virus.
Intel and Medical Informatics Corp. teamed up to help hospitals adopt the latter company’s Sickbay, a clinical surveillance and analytics platform intended to provide clinicians a single view of intensive care unit data. The collaboration is part of the chipmaker’s $50M Pandemic Response Technology Initiative.
K4Connect has communications technology offerings built to help residents at assisted living communities to communicate with their families and allow facility staff to monitor the safety of seniors.
The other Intel-backed companies are Amenity Analytics, Anodot, Avaamo, Cloudleaf, Duality, EchoPixel, Healx, Mesmer, Reveal Biosciences, Sprinklr and Synthego.
